Effects of Y27632 on keratinocyte procurement and wound healing

Clinical and Experimental Dermatology

Volumn 38, Issue 7, 2013, Pages 782-786

  Gandham, V D ^a   Maddala, R L ^b   Rao, V ^b   Jin, J Y ^a   Epstein, D L ^b   Hall, R P ^a   Zhang, J Y ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN; RHO KINASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPLANT; HUMAN; HUMAN CELL; KERATINOCYTE; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN CULTURE; SKIN FIBROBLAST; SKIN INJURY; WOUND CLOSURE; WOUND HEALING;

ADMINISTRATION, TOPICAL; AMIDES; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HUMANS; KERATINOCYTES; MICE; PYRIDINES; RHO-ASSOCIATED KINASES; WOUND HEALING;

EID: 84884903731     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12067     Document Type: Article

References (10)

1. Uehata M, Ishizaki T, Satoh H, et al,. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389: 990-4.
2. Ishizaki T, Uehata M, Tamechika I, et al,. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000; 57: 976-83.
3. Watanabe K, Ueno M, Kamiya D, et al,. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 2007; 25: 681-6.
4. Sivasubramaniyan K, Pal R, Totey S, Bhat VS,. Rho kinase inhibitor y27632 alters the balance between pluripotency and early differentiation events in human embryonic stem cells. Curr Stem Cell Res Ther 2010; 5: 2-12.
5. Chapman S, Liu X, Meyers C, et al,. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 2010; 120: 2619-26.
6. Terunuma A, Limgala RP, Park CJ, et al,. Efficient procurement of epithelial stem cells from human tissue specimens using a Rho-associated protein kinase inhibitor Y-27632. Tissue Eng Part A 2010; 16: 1363-8.
7. Lock FE, Hotchin NA,. Distinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte differentiation. PLoS ONE 2009; 4: e8190.
8. Jackson B, Peyrollier K, Pedersen E, et al,. RhoA is dispensable for skin development, but crucial for contraction and directed migration of keratinocytes. Mol Biol Cell 2011; 22: 593-605.
9. Routhier A, Astuccio M, Lahey D, et al,. Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth. Oncol Rep 2010; 23: 861-7.
10. Han YP, Nien YD, Garner WL,. Recombinant human platelet-derived growth factor and transforming growth factor-beta mediated contraction of human dermal fibroblast populated lattices is inhibited by Rho/GTPase inhibitor but does not require phosphatidylinositol-3′ kinase. Wound Repair Regen 2002; 10: 169-76.